CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,162,329
- in 14 filings, $13.9M under 10b5-1 plans
Net −$59,162,329. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-06 | Van Plew Daniel P EVP & General Mgr Industrial O | Shares withheld for taxes | −28,217 | $555.77 | $15.7M | 67,834 |
| 2020-05-06 | Van Plew Daniel P EVP & General Mgr Industrial O | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −33,079 | 52,500 | ||
| 2020-05-06 | Van Plew Daniel P EVP & General Mgr Industrial O | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −52,500 | 0 | ||
| 2020-05-06 | Tessier-Lavigne Marc Director | Exercise or conversion | +15,000 | $177.82 | $2.7M | 16,830 |
| 2020-05-06 | Tessier-Lavigne Marc Director | Sale | −1,025 | $562.65 | $577K | 15,805 |
| 2020-05-06 | Tessier-Lavigne Marc Director | Sale | −6,375 | $563.45 | $3.6M | 9,430 |
| 2020-05-06 | Tessier-Lavigne Marc Director | Sale | −6,600 | $564.45 | $3.7M | 2,830 |
| 2020-05-06 | Tessier-Lavigne Marc Director | Sale | −900 | $565.35 | $509K | 1,930 |
| 2020-05-06 | Tessier-Lavigne Marc Director | Sale | −100 | $566.01 | $57K | 1,830 |
| 2020-05-06 | Tessier-Lavigne Marc Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −15,000 | 0 | ||
| 2020-04-02 | VAGELOS P ROY Chairman of the Board | Gift | −433 | 143,900 | ||
| 2020-03-09 | Sanofi 10% owner | Sale | −128,914 | $489.65 | $63.1M | 20,421,899 |
| 2020-02-26 | STAHL NEIL EVP Research and Development | Gift | −750 | 20,979 | ||
| 2020-01-03 | VAGELOS P ROY Chairman of the Board | Gift | −564 | 144,333 | ||
| 2019-11-26 | RYAN ARTHUR F Director | Gift | −1,000 | 26,323 | ||
| 2019-11-22 | RYAN ARTHUR F Director | Gift | −1,500 | 27,323 | ||
| 2019-09-10 | Sanofi 10% owner | Sale | −172,904 | $281.15 | $48.6M | 20,550,813 |
| 2019-03-08 | Sanofi 10% owner | Sale | −131,115 | $412.17 | $54.0M | 20,723,717 |
| 2018-09-06 | Sanofi 10% owner | Sale | −104,552 | $406.68 | $42.5M | 23,654,384 |
| 2018-06-08 | Sanofi 10% owner | Sale | −121,601 | $309.31 | $37.6M | 23,758,936 |
Page 153 of 181 · 3,603 trades